DC Field | Value | Language |
---|---|---|
dc.contributor.author | K Kim | - |
dc.contributor.author | Ohman Kwon | - |
dc.contributor.author | Tae Young Ryu | - |
dc.contributor.author | Cho Rok Jung | - |
dc.contributor.author | Janghwan Kim | - |
dc.contributor.author | Jeong Ki Min | - |
dc.contributor.author | Dae Soo Kim | - |
dc.contributor.author | Mi Young Son | - |
dc.contributor.author | Hyun Soo Cho | - |
dc.date.accessioned | 2019-10-28T16:30:15Z | - |
dc.date.available | 2019-10-28T16:30:15Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1791-2997 | - |
dc.identifier.uri | 10.3892/mmr.2019.10431 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/18900 | - |
dc.description.abstract | Short-chain fatty acids (SCFAs; butyrate, propionate and acetate) are metabolites derived from the gut microbiota via dietary fiber fermentation. In colon cancer, treatment with SCFAs, mainly butyrate and propionate, suppresses cell proliferation, migration and invasion. Furthermore, although sodium butyrate is known to induce cell apoptosis in lung cancer, the anticancer effects of sodium propionate (SP) on lung cancer are not well understood. In the present study, SP treatment induced cell cycle arrest, especially in the G2/M phase, and cell apoptosis in the H1299 and H1703 lung cancer cell lines. As determined by reverse transcription-quantitative PCR and western blotting, Survivin and p21 expression levels were significantly affected by SP treatment, suggesting that SP treatment suppressed cell proliferation in these lung cancer cell lines. Thus, it was proposed that the SP-mediated regulation of Survivin and p21 in lung cancer may be applicable to lung cancer therapy. | - |
dc.publisher | Spandidos Publ Ltd | - |
dc.title | Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer | - |
dc.title.alternative | Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer | - |
dc.type | Article | - |
dc.citation.title | Molecular Medicine Reports | - |
dc.citation.number | 2 | - |
dc.citation.endPage | 1574 | - |
dc.citation.startPage | 1569 | - |
dc.citation.volume | 20 | - |
dc.contributor.affiliatedAuthor | Ohman Kwon | - |
dc.contributor.affiliatedAuthor | Tae Young Ryu | - |
dc.contributor.affiliatedAuthor | Cho Rok Jung | - |
dc.contributor.affiliatedAuthor | Janghwan Kim | - |
dc.contributor.affiliatedAuthor | Jeong Ki Min | - |
dc.contributor.affiliatedAuthor | Dae Soo Kim | - |
dc.contributor.affiliatedAuthor | Mi Young Son | - |
dc.contributor.affiliatedAuthor | Hyun Soo Cho | - |
dc.contributor.alternativeName | 김광교 | - |
dc.contributor.alternativeName | 권오만 | - |
dc.contributor.alternativeName | 류태영 | - |
dc.contributor.alternativeName | 정초록 | - |
dc.contributor.alternativeName | 김장환 | - |
dc.contributor.alternativeName | 민정기 | - |
dc.contributor.alternativeName | 김대수 | - |
dc.contributor.alternativeName | 손미영 | - |
dc.contributor.alternativeName | 조현수 | - |
dc.identifier.bibliographicCitation | Molecular Medicine Reports, vol. 20, no. 2, pp. 1569-1574 | - |
dc.identifier.doi | 10.3892/mmr.2019.10431 | - |
dc.subject.keyword | Apoptosis | - |
dc.subject.keyword | Cell cycle | - |
dc.subject.keyword | Lung cancer | - |
dc.subject.keyword | P21 | - |
dc.subject.keyword | Propionate | - |
dc.subject.keyword | Survivin | - |
dc.subject.local | apoptosis | - |
dc.subject.local | Apoptosis | - |
dc.subject.local | cell cycle | - |
dc.subject.local | Cell cycle | - |
dc.subject.local | lung cancer | - |
dc.subject.local | Lung Cancer | - |
dc.subject.local | Lung cancer | - |
dc.subject.local | P21 | - |
dc.subject.local | p21 | - |
dc.subject.local | Propionate | - |
dc.subject.local | Survivin | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.